SCHEMBL23631572

SCHEMBL23631572

O=C(O)CNC(=O)Cn1ccc2ccc(-c3ccc4c(c3)CCO4)cc21

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ FFAR1 O14842 1/20 0.41
▸ PLA2G10 O15496 1/20 0.40
▸ KDM4E B2RXH2 3/20 0.39
▸ ALDH1A1 P00352 2/20 0.39
▸ GLA P06280 1/20 0.39
▸ HPGD P15428 1/20 0.39
▸ TSHR P16473 1/20 0.39
▸ HTT P42858 1/20 0.39
▸ HSD17B10 Q99714 1/20 0.39
▸ DYRK1A Q13627 1/20 0.39
▸ ERN1 O75460 1/20 0.38
▸ NPC1 O15118 3/20 0.37
▸ RAB9A P51151 3/20 0.37
▸ SMN1; SMN2 Q16637 1/20 0.37
▸ MAPK1 P28482 1/20 0.37
▸ CYP11B2 P19099 2/20 0.37
▸ NTSR1 P30989 2/20 0.37
▸ POLB P06746 1/20 0.37
▸ PLAU P00749 1/20 0.37
▸ FABP4 P15090 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23631692 0.92 NTSR1 (0.43) FFAR1PLA2G10KDM4EALDH1A1DYRK1A
SCHEMBL23631570 0.80 KDM4E (0.52) KDM4EALDH1A1GLAHPGDTSHR
SCHEMBL23631661 0.79 KDM4E (0.46) KDM4EALDH1A1GLAHPGDTSHR
SCHEMBL23631683 0.79 CHEK1 (0.38) KDM4EALDH1A1GLAHPGDTSHR
SCHEMBL23631689 0.78 KDM4E (0.45) KDM4EALDH1A1GLAHPGDTSHR
SCHEMBL23631657 0.78 KDM4E (0.45) KDM4EALDH1A1GLAHPGDTSHR
SCHEMBL23631579 0.76 NTSR1 (0.44) KDM4EALDH1A1GLAHPGDTSHR
SCHEMBL23631655 0.75 ALDH1A1 (0.61) KDM4EALDH1A1GLAHPGDTSHR
SCHEMBL23631589 0.74 ALDH1A1 (0.47) KDM4EALDH1A1GLAHPGDTSHR
SCHEMBL23631652 0.74 KMO (0.62) KDM4EALDH1A1GLAHPGDTSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210214359-A1 Compounds and Methods for Treating Bacterial Infections UNIV NEW YORK (US) 2021-07-15 — — US claimed
US-20210214359-A1 Compounds and Methods for Treating Bacterial Infections UNIV NEW YORK (US) 2021-07-15 — — US disclosed
US-20210214359-A1 Compounds and Methods for Treating Bacterial Infections UNIV NEW YORK (US) 2021-07-15 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210214359-A1 Compounds and Methods for Treating Bacterial Infections CBS, MPO, QSOX1 FFAR1 3401/4885PLA2G10 828/4885KDM4E 2239/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback